Ireland· IE-PA-PA2165/017/001

Ceftriaxone 1 g powder for solution for injection/infusion

A ceftriaxone product containing ceftriaxone sodium, registered in Ireland by AS Kalceks. The same ATC class is registered in 19 of our 19 countries.

ATC J01DD04

Checked against HPRA (Ireland) on September 28, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about ceftriaxone sodiumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Ceftriaxone is registered in 19 of 19 countries.

Countries holding a registration under ATC J01DD04 (ceftriaxone), each read from that country’s own register.

This record: Ireland, from HPRA (Ireland)
11 of them publish a price we can compare per daily dose

Search ceftriaxone products by name

Ceftriaxone · ATC J01DD04

19 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ceftriaxone costs, country by country.

Normalised to the WHO defined daily dose (2 g), the median price runs from $3.23 in Finland to $33.98 in Switzerland — a ×11 gap.

4 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Ceftriaxone · price per daily dose (2 g)

USD · FX 28 Sept 2026

CH Switzerland$33.98
FR France$13.68
ES Spain$5.69
FI Finland$3.23

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

HPRA (Ireland)

Active substance: Ceftriaxone sodium
Manufacturer: AS Kalceks
Country: Ireland (IE)
ATC code: J01DD04
ATC class: Ceftriaxone
Defined daily dose: 2 g, P
Reimbursed: Not published by this register
Source register: HPRA (Ireland)
Last checked: September 28, 2026

Packs & prices · 1

ie_pa_number
PA2165/017/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

233 interactions on record for ceftriaxone.

Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check ceftriaxone against other medicines How interaction checks work

Ceftriaxone · interactions on record

233 records

7 severe
20 moderate
3 minor
203 info

Most severe, free to view

Calcium gluconateA12AA03severe
Calcium chlorideA12AA07severe
Calcium glucoheptonateA12AA10severe
Calcium chlorideB05XA07severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ceftriaxone in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ceftriaxone products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Ceftriaxon Aptapharma, Ceftriaxon Ashcure
Belgium · Ceftriaxon Hameln, Ceftriaxone Fresenius Kabi
Bulgaria · Медаксон, Цефамед
Cyprus · Ceftriaxone Sapiens, Ceftrix
Czechia · Ceftriaxon Aptapharma, Ceftriaxon Kabi
Germany · Ceftriaxon Cnp, Ceftriaxon Dali Pharma
Denmark · Ceftriaxon Fresenius Kabi, Ceftriaxon Hameln
Estonia · ceftriaxone Kabi, Ceftriaxone Mip
Spain · Ceftriaxona Fresenius Kabi, Ceftriaxona Ldp Torlan
Finland · Ceftriaxon Fresenius Kabi, Ceftriaxon Hameln
France · Ceftriaxone Almus, Ceftriaxone Arrow
United Kingdom (Northern Ireland) · Ceftriaxone, Ceftriaxone Aft Pharma Uk
Greece · Bresec, Bresec(Iv)
Croatia · Ceftriakson Aptapharma, Ceftriakson Pontus
Hungary · Ceftriaxon Aptapharma, Ceftriaxon Kabi
Iceland · Ceftriaxon Fresenius Kabi, Ceftriaxon Navamedic
Italy · Bixon, Caritex
Lithuania · Ceftriaxone Ashcure, Ceftriaxone Kabi
Luxembourg · Ceftriaxone Fresenius Kabi, Rocephine
Latvia · Ceftriaxon Mip, Ceftriaxone Ashcure
Malta · Ceftriaxone Ashcure, Ceftriaxone Dali Pharma
Netherlands · Ceftriaxon Fresenius Kabi, Ceftriaxon Hameln
Norway · Ceftriaxon Fresenius Kabi, Ceftriaxon Hameln
Poland · Biotrakson, Ceftriaxon Aptapharma
Portugal · Betasporina, Betasporina Im
Romania · Cefort, Ceftriaxonă Aptapharma
Sweden · Ceftriaxon Fresenius Kabi, Ceftriaxon Hameln
Slovenia · Ceftriakson Aptapharma, Ceftriakson Pontus
Slovakia · Ceftriaxón Aptapharma, Ceftriaxon Kabi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/e0e8271e-446c-46a9-954e-29c104ad8562
GET /v1/drugs/e0e8271e-446c-46a9-954e-29c104ad8562?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder for solution for injection/infusion",
  "routes": [
    "Intramuscular use",
    "Intravenous use"
  ],
  "source": "hpra",
  "atc_all": [
    "J01DD",
    "J01DD04"
  ],
  "strength": null,
  "pa_number": "PA2165/017/001",
  "substances": [
    "Ceftriaxone sodium"
  ],
  "legal_basis": "Hybrid application (Article 10(3) of Directive No 2001/83/EC)",
  "market_info": "Not marketed",
  "authorised_at": "13/01/2023",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

API reference MCP server Plans

See everything about ceftriaxone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console